Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease

Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease

10.1002/ajmg.b.30359

Saved in:

Bibliographic Details
Main Authors:	Tan, E.K., Lu, Z.Y., Fook-Chong, S.M.C., Tan, E., Shen, H., Chua, E., Yih, Y., Teo, Y.Y., Zhao, Y.
Other Authors:	STATISTICS & APPLIED PROBABILITY
Format:	Article
Published:	2014
Subjects:	A2a adenosine receptor Caffeine Parkinson's disease Polymorphism
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/105143
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers
by: Tan, E.-K., et al.
Published: (2014)

Clinical evidence linking coffee and tea intake with Parkinson's disease
by: Prakash, K.M., et al.
Published: (2014)

Modulation of DNA synthesis via adenosine receptors in human epidermoid carcinoma (A431) cells
by: Tey, H.-B., et al.
Published: (2014)

Dopamine D2 receptor taqIA and TaqIB polymorphisms in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018)

Caffeine as a preventive supplement for Parkinson’s disease: A meta-analysis
by: Siega, Swizza Rivera, et al.
Published: (2023)

Polymorphism in semaphorin 5A (Sema5A) gene is not a marker of Parkinson's disease risk
by: Bialecka M., et al.
Published: (2018)

The role of adenosine, adenosine receptors and transporters in the modulation of cell death
by: SUN WENTIAN
Published: (2010)

Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: A study in ethnic Chinese
by: Tan E.-K., et al.
Published: (2018)

Adenosine induced apoptosis in BHK cells via P1 receptors and equilibrative nucleoside transporters
by: Sun, W., et al.
Published: (2013)

Analysis of the UCHL1 genetic variant in Parkinson's disease among Chinese
by: Tan, E.K., et al.
Published: (2014)

DISCOVERY OF INDOLYL PIPERAZINYLPYRIMIDINES WITH DUAL-TARGET PROFILES ADENOSINE A2¿ AND DOPAMINE D2 RECEPTORS FOR PD TREATMENT
by: SHAO YI-MING
Published: (2015)

Association of HLA locus variant in parkinson's disease
by: Zhao, Y., et al.
Published: (2014)

Case-control study of UCHL1 S18Y variant in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018)

Genetic analysis of Nurr1 haplotypes in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018)

Nurr1 mutational screen in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018)

The A3 adenosine receptor as multifaceted therapeutic target: Pharmacology, medicinal chemistry, and in silico approaches
by: Cheong, S.L., et al.
Published: (2014)

LRRK2 in Parkinson's disease: Genetic and clinical studies from patients
by: Kumari U., et al.
Published: (2018)

Association study of p53 codon 72 polymorphism in Parkinson's disease
by: Siddique, M.M., et al.
Published: (2016)

Concentrative transport of adenosine in murine splenocytes: Limitation by an ecto-adenosine deaminase
by: Lee, C.-W., et al.
Published: (2014)

Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo- pyrimidines as potent human A3 adenosine receptor antagonists
by: Cheong, S.L., et al.
Published: (2014)

Adenosine and its receptor agonists regulate nitric oxide production in raw 264.7 Macrophages via both receptor binding and its downstream metabolites - Inosine
by: Khoo, H.E., et al.
Published: (2014)

Evidence for A1 and A(2B) adenosine receptors in baby hamster kidney (BHK) cells
by: Mittal, R.A., et al.
Published: (2013)

Analysis of MDR1 haplotypes in Parkinson's disease in a white population
by: Tan, E.-K., et al.
Published: (2014)

Does the combination of optimal substitutions at the C 2-, N 5- and N 8-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A 3 adenosine receptors?
by: Cheong, S.L., et al.
Published: (2014)

Differential expression of adenosine A1 receptors in colorectal cancer and related mucosa
by: Khoo, H.-E., et al.
Published: (2014)

Association between allele 1 of T102C polymorphism, 5-hydroxytryptamine 2a receptor gene and schizophrenia in Chinese males in Singapore
by: Tay, A.H.N., et al.
Published: (2014)

The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinsons disease, levodopa treatment response, and complications
by: Bialecka M., et al.
Published: (2018)

DESIGN, SYNTHESIS, PHARMACOLOGICAL AND MOLECULAR MODELING EVALUATIONS OF NEW PYRAZOLO-TRIAZOLO-PYRIMIDINE DERIVATIVES AS HUMAN A3 ADENOSINE RECEPTOR ANTAGONISTS
by: CHEONG SIEW LEE
Published: (2011)

Evidence of increased odds of essential tremor in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018)

Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson's disease in a Han-Chinese population
by: Zhang, Z.-J., et al.
Published: (2015)

A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease
by: Krüger R., et al.
Published: (2018)

Effects of adenosine receptor agonists on nitric oxide release in mouse during endotoxemia
by: Wei, M.H., et al.
Published: (2011)

Effects of repeated caffeine administration on cognition and mood
by: Wing, H.L.
Published: (2011)

Effects of repeated caffeine administration on cognition and mood
by: Wing, H.L.
Published: (2011)

Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's disease
by: Lim S.W., et al.
Published: (2018)

Genetic analysis of LRRK2 A419V variant in ethnic Chinese
by: Li, N.-N., et al.
Published: (2014)

THE AMPK-PGC-1a AXIS IN NEUROPROTECTION: IMPLICATIONS FOR ENERGY DEFICITS IN PARKINSON'S DISEASE
by: HANG LITING
Published: (2020)

A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
by: Tay, Apple Hui Min, et al.
Published: (2023)

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
by: Tan E.K., et al.
Published: (2018)

Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process
by: Pastorin, G., et al.
Published: (2014)